tiprankstipranks
Mabpharm Limited (HK:2181)
:2181
Hong Kong Market
2181
Mabpharm Limited
RESEARCH TOOLSreports

Mabpharm Limited (2181) Ratios

0 Followers

Mabpharm Limited Ratios

HK:2181's free cash flow for Q2 2025 was ¥0.88. For the 2025 fiscal year, HK:2181's free cash flow was decreased by ¥ and operating cash flow was ¥0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 0.81 1.17 1.08 1.07 1.05
Quick Ratio
 0.56 0.82 0.76 0.53 0.83
Cash Ratio
 0.20 0.29 0.55 0.18 0.35
Solvency Ratio
 0.11 -0.08 -0.18 -0.31 -0.83
Operating Cash Flow Ratio
 0.19 -0.01 0.18 -0.30 -0.85
Short-Term Operating Cash Flow Coverage
 0.44 -0.05 0.53 0.00 -269.92
Net Current Asset Value
¥ -562.10M¥ -561.51M¥ -487.71M¥ -315.46M¥ -50.15M
Leverage Ratios
Debt-to-Assets Ratio
 0.28 0.29 0.25 0.14 0.05
Debt-to-Equity Ratio
 2.08 3.30 1.27 0.32 0.08
Debt-to-Capital Ratio
 0.68 0.77 0.56 0.24 0.07
Long-Term Debt-to-Capital Ratio
 0.30 0.65 0.33 0.17 0.00
Financial Leverage Ratio
 7.33 11.43 5.05 2.29 1.49
Debt Service Coverage Ratio
 0.46 -0.75 -1.18 -21.13 -78.12
Interest Coverage Ratio
 0.46 -11.34 -21.09 -31.48 -123.81
Debt to Market Cap
 0.17 0.23 0.12 0.05 <0.01
Interest Debt Per Share
 0.08 0.07 0.07 0.03 0.01
Net Debt to EBITDA
 3.54 -3.00 -0.62 -0.61 0.14
Profitability Margins
Gross Profit Margin
85.91%84.96%86.32%72.50%79.76%
EBIT Margin
0.75%-46.34%-229.21%-364.16%-349.10%
EBITDA Margin
9.60%-26.26%-159.57%-271.97%-296.16%
Operating Profit Margin
0.75%-46.34%-231.74%-404.61%-358.97%
Pretax Profit Margin
0.65%-49.55%-240.19%-377.01%-352.00%
Net Profit Margin
8.79%-49.55%-240.19%-376.66%-352.00%
Continuous Operations Profit Margin
8.79%-49.55%-240.19%-377.01%-352.00%
Net Income Per EBT
1358.51%100.00%100.00%99.91%100.00%
EBT Per EBIT
86.76%106.91%103.65%93.18%98.06%
Return on Assets (ROA)
4.87%-12.59%-20.23%-22.96%-32.42%
Return on Equity (ROE)
43.89%-143.87%-102.10%-52.53%-48.46%
Return on Capital Employed (ROCE)
0.77%-17.00%-28.10%-31.03%-44.75%
Return on Invested Capital (ROIC)
0.56%-14.93%-23.93%-30.45%-44.08%
Return on Tangible Assets
5.32%-13.02%-20.23%-22.96%-32.42%
Earnings Yield
3.12%-11.80%-12.18%-13.30%-8.69%
Efficiency Ratios
Receivables Turnover
 3.90 2.69 4.49 5.87 104.52
Payables Turnover
 2.99 3.32 1.19 0.93 1.30
Inventory Turnover
 0.66 0.35 0.12 0.15 0.32
Fixed Asset Turnover
 1.12 0.42 0.13 0.08 0.13
Asset Turnover
 0.55 0.25 0.08 0.06 0.09
Working Capital Turnover Ratio
 -17.65 6.48 4.50 4.39 0.44
Cash Conversion Cycle
 524.33 1.07K 2.90K 2.06K 881.37
Days of Sales Outstanding
 93.51 135.82 81.34 62.22 3.49
Days of Inventory Outstanding
 552.97 1.04K 3.12K 2.39K 1.16K
Days of Payables Outstanding
 122.15 110.05 306.50 393.75 279.78
Operating Cycle
 646.48 1.18K 3.21K 2.46K 1.16K
Cash Flow Ratios
Operating Cash Flow Per Share
 0.03 >-0.01 0.01 -0.01 -0.05
Free Cash Flow Per Share
 0.01 -0.02 <0.01 -0.04 -0.08
CapEx Per Share
 0.01 0.01 <0.01 0.03 0.04
Free Cash Flow to Operating Cash Flow
 0.52 15.52 0.67 3.20 1.75
Dividend Paid and CapEx Coverage Ratio
 2.08 -0.07 3.01 -0.45 -1.34
Capital Expenditure Coverage Ratio
 2.08 -0.07 3.01 -0.45 -1.34
Operating Cash Flow Coverage Ratio
 0.32 -0.01 0.22 -0.45 -4.30
Operating Cash Flow to Sales Ratio
 0.16 -0.02 0.66 -1.02 -2.41
Free Cash Flow Yield
2.97%-5.86%2.23%-11.49%-10.37%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 32.07 -8.48 -8.21 -7.52 -11.51
Price-to-Sales (P/S) Ratio
 2.82 4.20 19.72 28.33 40.52
Price-to-Book (P/B) Ratio
 11.46 12.19 8.38 3.95 5.58
Price-to-Free Cash Flow (P/FCF) Ratio
 33.66 -17.06 44.82 -8.70 -9.65
Price-to-Operating Cash Flow Ratio
 17.49 -264.65 29.95 -27.85 -16.84
Price-to-Earnings Growth (PEG) Ratio
 0.11 0.22 13.99 0.27 -0.20
Price-to-Fair Value
 11.46 12.19 8.38 3.95 5.58
Enterprise Value Multiple
 32.92 -19.00 -12.98 -11.03 -13.54
Enterprise Value
 2.02B 1.29B 1.81B 1.68B 3.32B
EV to EBITDA
 32.92 -19.00 -12.98 -11.03 -13.54
EV to Sales
 3.16 4.99 20.72 29.99 40.10
EV to Free Cash Flow
 37.72 -20.26 47.08 -9.21 -9.55
EV to Operating Cash Flow
 19.60 -314.37 31.46 -29.48 -16.66
Tangible Book Value Per Share
 0.04 0.01 0.05 0.10 0.15
Shareholders’ Equity Per Share
 0.04 0.02 0.05 0.10 0.15
Tax and Other Ratios
Effective Tax Rate
 -12.59 0.00 0.00 <0.01 0.00
Revenue Per Share
 0.16 0.06 0.02 0.01 0.02
Net Income Per Share
 0.01 -0.03 -0.05 -0.05 -0.07
Tax Burden
 13.59 1.00 1.00 1.00 1.00
Interest Burden
 0.87 1.07 1.05 1.04 1.01
Research & Development to Revenue
 0.08 0.29 1.41 2.65 3.18
SG&A to Revenue
 0.77 0.70 0.24 0.39 0.26
Stock-Based Compensation to Revenue
 0.02 0.05 0.15 0.17 0.15
Income Quality
 -3.75 0.03 -0.27 0.27 0.68
Currency in CNY